Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.45 USD | +0.01% | -1.25% | +28.07% |
Financials (USD)
Sales 2024 * | 5.3B | Sales 2025 * | 5.77B | Capitalization | 8.6B |
---|---|---|---|---|---|
Net income 2024 * | 414M | Net income 2025 * | 464M | EV / Sales 2024 * | 2.08 x |
Net Debt 2024 * | 2.42B | Net Debt 2025 * | 2.14B | EV / Sales 2025 * | 1.86 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
19
x | Employees | 27,209 |
Yield 2024 * |
0.7% | Yield 2025 * |
0.7% | Free-Float | 85.64% |
Latest transcript on Encompass Health Corporation
1 day | +0.01% | ||
1 week | -1.25% | ||
Current month | +2.48% | ||
1 month | +8.69% | ||
3 months | +16.18% | ||
6 months | +32.83% | ||
Current year | +28.07% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 62 | 92-12-31 |
Douglas Coltharp
DFI | Director of Finance/CFO | 62 | 10-05-05 |
Chief Tech/Sci/R&D Officer | 64 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslye Katz
BRD | Director/Board Member | 69 | 13-01-24 |
Chairman | 62 | 19-12-31 | |
Director/Board Member | 68 | 21-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.44% | 8 M€ | +5.66% | ||
1.39% | 2 M€ | +10.27% | ||
1.09% | 231 M€ | -1.00% | ||
1.09% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 85.45 | +0.01% | 355,324 |
24-05-16 | 85.44 | -1.89% | 654,919 |
24-05-15 | 87.09 | +0.28% | 425,238 |
24-05-14 | 86.85 | +0.78% | 549,984 |
24-05-13 | 86.18 | -0.40% | 477,290 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.07% | 8.6B | |
-18.52% | 16.6B | |
+5.41% | 12.87B | |
+3.98% | 11.78B | |
+4.38% | 10.28B | |
-4.98% | 7.64B | |
+6.76% | 6.76B | |
+7.33% | 6.4B | |
+48.17% | 4.58B | |
-3.38% | 4.33B |
- Stock Market
- Equities
- EHC Stock